News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Solarvest Announces Annual General Meeting of Shareholders
April 3, 2024
·
2 min read
Telo Genomics’ Flagship MRD Clinical Trial Expands into Multi-Center Trial
April 2, 2024
·
4 min read
Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 2, 2024
·
3 min read
Cardiol Therapeutics Announces Year-End 2023 Update on Operations
April 2, 2024
·
12 min read
Business
AquaBounty Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
April 1, 2024
·
14 min read
Kiora Pharmaceuticals to Present Additional Data from Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting
March 28, 2024
·
5 min read
Drug Development
Results of Adaptimmune’s SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet
March 28, 2024
·
4 min read
Drug Delivery
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology
March 27, 2024
·
2 min read
ME Therapeutics Holdings Inc. Announces Upcoming Participation in the 2024 Bloom Burton & Co Health Care Conference and Interview On CSE TV
March 26, 2024
·
1 min read
FDA
FDA Approves Medexus’s Supplemental Biologics License Application for IXINITY(R) to Treat Hemophilia B in Pediatric Patients
March 26, 2024
·
7 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us